Due Diligence Capital Notes

There's a peculiar detail buried inside AST SpaceMobile's November 2025 8-K filing that stopped me cold when I first read it. The company — through a subsidiary — borrowed $420 million from UBS AG, one of the world's largest banks. But to secure that loan, the borrowing entity is required to hold at least $428.4 million in cash inside a collateral account at all times. Read that again: they borrowed $420 million and had to lock up more than $420 million to do it.

On the surface, this looks absurd. If you already have the cash, why borrow? But once you understand the subsidiary structure ASTS engineered for this deal, it becomes one of the more elegant capital maneuvers I've seen from a pre-profitability satellite company — and it tells you something important about how management thinks about protecting shareholders while still funding an enormously capital-intensive buildout of its Block 2 BlueBird satellite constellation.

The Subsidiary Shell: BackstopCo, LLC

The entity that actually signed the loan agreement with UBS is not AST SpaceMobile, Inc. — the publicly traded company you and I can buy shares in. It's a subsidiary called BackstopCo, LLC, which sits inside AST & Science, LLC (the operating company beneath the public parent). This distinction is not a technicality. As the Form 8-K filed November 3, 2025 states explicitly:

"AST SpaceMobile, Inc. will not be liable as a borrower or guarantor or otherwise for any payments owing in connection with the Loan Facility."

That single sentence is doing a lot of work. It means that if BackstopCo were somehow to default on this loan, UBS's legal recourse does not extend to the publicly traded parent. ASTS shareholders are, in a structural sense, ring-fenced — insulated from the direct liability. AST LLC does serve as a limited guarantor, but only for specifically defined "bad boy" actions (think fraud or deliberate covenant violations), and even then lender recourse is capped at AST LLC's equity interest in BackstopCo — not the parent's broader asset base.

How a Cash-Collateralized Loan Actually Works

A cash-collateralized loan is exactly what it sounds like: instead of pledging equipment, intellectual property, or receivables as security, the borrower pledges cash itself. The lender — UBS in this case — is taking almost zero credit risk, because if the borrower defaults, the lender simply seizes the cash in the collateral account.

This structure explains several things simultaneously:

Why UBS agreed to lend to a pre-profitability satellite startup. ASTS is not yet generating meaningful free cash flow — the cash left over after operating expenses and capital investment. A conventional bank loan to a company at this stage would carry junk-bond-level interest rates, if it were available at all. Cash collateral eliminates the credit risk entirely, turning the loan from a bet on ASTS's business model into something closer to a secured lending arrangement against liquid assets.
Why the interest rate is relatively modest. The facility accrues at Term SOFR plus 2.0% per annum — a floating rate tied to the Secured Overnight Financing Rate, the benchmark US short-term rate that replaced LIBOR after 2023. The filing is explicit: "The loan under the Loan Facility will bear interest at a floating rate equal to Term SOFR plus 2.0% per annum and will mature on the earlier of (a) October 31, 2028 and (b) the date on which the Loan Facility shall be terminated or accelerated." With SOFR in the 4–5% range through late 2025, the all-in borrowing cost is roughly 6–7%. High-yield bonds from similarly sized speculative companies often carry coupons of 9–12%. The cash collateral is precisely why ASTS gets bank-loan pricing.
Why the 102% coverage floor matters. BackstopCo is required to maintain cash or cash equivalents in its collateral account "in an amount equal to (or in excess of) 102.0% of the outstanding principal amount." At $420 million outstanding, that's a minimum of ~$428.4 million locked in the collateral account at all times. The 2% buffer absorbs accrued interest and potential breakage costs, ensuring UBS is always fully secured with a margin of safety.

The Financial Engineering in Four Steps

The elegance only becomes visible when you walk through the actual sequence of events:

ASTS accumulates cash on its balance sheet. Through prior equity raises — including multiple ATM (at-the-market) offerings, where shares are sold gradually into the market at prevailing prices — AST & Science, LLC builds up a substantial cash reserve sufficient to capitalize a subsidiary.
BackstopCo is funded with that cash. AST LLC transfers approximately $428.4 million into BackstopCo, LLC, which deposits it into a UBS collateral account. At this point, no loan has been drawn — ASTS has simply moved existing cash into a legally distinct entity.
BackstopCo draws the $420 million loan. With the collateral in place, UBS funds the facility. BackstopCo now holds $428.4M in the locked collateral account and receives $420M in new, freely deployable cash. The net effect: ASTS has effectively extended its operational liquidity by $420 million, trading immobilized collateral for unrestricted working capital.
The $420M flows toward satellite manufacturing. This capital funds Block 2 BlueBird production, launch contracts, and ground infrastructure — the activities that determine whether ASTS achieves commercial-scale coverage before competitors close the technical gap. The loan matures October 31, 2028, providing a three-year runway with no prepayment penalty beyond standard breakage costs.

What makes this genuinely clever is the interest arithmetic. The $428M collateral is almost certainly invested in short-term Treasuries or money-market instruments earning something close to the SOFR rate — say, 4.5%. The loan costs SOFR + 2.0%, roughly 6.5%. The net cost of carry — the difference between what you earn on the collateral and what you pay on the loan — is approximately 2%. On a $420 million facility, that's roughly $8.4 million per year in net financing cost. For a three-year extension of runway at commercial-scale satellite deployment pace, that is an extraordinarily efficient use of capital.

The covenants filed alongside the agreement, signed by Andrew M. Johnson, ASTS's EVP, CFO and Chief Legal Officer, restrict both BackstopCo and AST LLC from incurring additional indebtedness, disposing of assets, executing mergers, or entering affiliate transactions without lender consent. These negative covenants — contractual restrictions on what the borrower cannot do, as opposed to affirmative obligations — are standard in secured lending but apply at the AST LLC operating level, not just inside BackstopCo.

What This Signals About the Block 2 Buildout

ASTS is in a critical phase. The company's first-generation BlueBird satellites proved the core thesis: that an ordinary smartphone could connect to a satellite in low Earth orbit without any specialized hardware. Block 2 is the commercial-scale deployment — a constellation dense enough to deliver consistent, broadband-grade coverage across carrier partner networks worldwide.

That buildout is expensive and time-sensitive. Every quarter of manufacturing delay is a quarter competitors can close the technical gap. Raising $420 million through a structure that does not add direct liability to the parent, carries below-market interest rates because of cash collateral, and requires zero new equity issuance — no shareholder dilution — is the kind of capital decision that lets management stay focused on execution. For additional filing details and the full covenant schedule, AST SpaceMobile's complete 8-K history is accessible via the SEC EDGAR filing index for ASTS.

What Could Break This Thesis

No financing structure is without its failure modes, and this one has four I want to name directly:

The liquidity trap. BackstopCo must continuously hold ≥102% of the outstanding principal in its collateral account. That $428M+ is structurally locked and unavailable for satellite manufacturing, launch contracts, or any other operational use for the duration of the loan. If ASTS encounters unexpected capital demands — a launch failure, a manufacturing cost overrun, a carrier partnership requiring upfront infrastructure — management cannot simply draw from that collateral pool. The structural illiquidity is this deal's most significant hidden cost.
Floating-rate exposure. The loan accrues at Term SOFR + 2.0% with no disclosed rate cap. If US benchmark rates were to spike — say, in response to renewed inflation — debt service costs rise in lockstep. A 200-basis-point increase in SOFR would add roughly $8.4 million to annual interest expense. Manageable at current satellite economics, but worth monitoring in any rate-shock scenario.
Cross-default contagion. Standard loan agreements include cross-default provisions — clauses allowing the lender to accelerate the full principal if the borrower defaults on any other material agreement. If BackstopCo or AST LLC were to trip a covenant in a separate contract, UBS could call the full $420 million immediately. Given the complexity of ASTS's supply chain agreements and launch contracts, this is not a theoretical risk.
Covenant drag on parent strategy. The negative covenants binding AST LLC — restrictions on new debt, asset sales, mergers, and affiliate transactions — apply at the operating company level, not just inside BackstopCo. This could complicate future capital raises, strategic partnerships, or any transaction structure that involves asset transfers within the ASTS corporate family before October 2028. Strategic pivots may require lender consent to execute.

Where This Leaves the Investment Thesis

What I find most telling about this transaction is what it reveals about management's priorities at this stage. ASTS could have issued more equity through an ATM facility. It could have pursued a convertible bond — a debt instrument that bond buyers can convert into equity at a preset price if the stock rises far enough, a tool Strategy has used repeatedly. Instead, ASTS chose a structure that preserves the share count, keeps direct liability away from the parent, and prices the capital cheaply by pledging cash that was already on the balance sheet.

That's not improvisation. That's the move of a management team that believes the Block 2 constellation will be in orbit and generating revenue well before October 2028 — and wants to reach that milestone without leaving shareholders exposed to balance-sheet risk along the way. Whether that confidence is warranted depends entirely on execution: manufacturing throughput, launch vehicle availability, and the pace at which carrier partners convert signed agreements into active commercial coverage. But as a capital allocation decision evaluated in isolation, the BackstopCo structure is difficult to fault.